Literature DB >> 10886393

Tetanus toxin L chain is processed by major histocompatibility complex class I and class II pathways and recognized by CD8+ or CD4+ T lymphocytes.

I Kerblat1, S Tongiani-Dahshan, C Aude-Garcia, M Villiers, C Drouet, P N Marche.   

Abstract

Tetanus toxin (TeNT) is a heterodimeric protein antigen, whose light chain (L) is translocated in the cytosol of neuronal target cells specifically to cleave its substrates, vesicle-associated membrane protein-2 (VAMP-2, or synaptobrevin) or cellubrevin. We report that the L chain behaves as a nominal antigen recognized by specific T-cell clones upon either class I- or II-restricted presentation. Three types of responses are observed: (i) a TeNT- and L-specific CD8+ T-cell response, that can be inhibited in a dose-dependent manner by the proteasome inhibitor clasto-Lactacystin beta-lactone; (ii) a CD4+ T-cell response specific for L but not TeNT, with recognition of a determinant processed in a chloroquine-sensitive and brefeldin A-resistant compartment; (iii) a CD4+ T-cell response against both L and TeNT, with processing in a brefeldin A-sensitive compartment. The L chain processing was investigated in U937 cells by internalization and localization of L chain by separation of the cell content by differential centrifugation experiments. After incubation with TeNT or L chain in the presence of H chain, the L chain was predominantly distributed in the cytosolic fraction, whereas incubation with L alone led to localization in a lysosome/membrane fraction. The distribution of the TeNT L chain in both cytosolic and endocytic compartments of the antigen-presenting cell accounted for its processing by both class I and class II pathways. Furthermore, an epitope overlapping with the zinc-binding region was recognized by CD4+ and CD8+ T cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10886393      PMCID: PMC2327006          DOI: 10.1046/j.1365-2567.2000.00032.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  40 in total

1.  Proteolytic fragmentation of tetanus toxin by subcellular fractions of JY, a B lymphoblastoid cell line.

Authors:  A Reboul; J Arvieux; J F Wright; M G Colomb
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

2.  Formation of covalent C3b-tetanus toxin complexes: a tool for the in vitro study of antigen presentation.

Authors:  M B Villiers; C L Villiers; J F Wright; C M Maison; M G Colomb
Journal:  Scand J Immunol       Date:  1991-11       Impact factor: 3.487

3.  Involvement of the Zn-binding region of tetanus toxin in B and T recognition. Influence of Zn fixation.

Authors:  M B Villiers; F M Gabert; M R Jacquier; C L Villiers; M G Colomb
Journal:  Mol Immunol       Date:  1993-02       Impact factor: 4.407

4.  Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.

Authors:  P Panina-Bordignon; A Tan; A Termijtelen; S Demotz; G Corradin; A Lanzavecchia
Journal:  Eur J Immunol       Date:  1989-12       Impact factor: 5.532

5.  Delineation of several DR-restricted tetanus toxin T cell epitopes.

Authors:  S Demotz; A Lanzavecchia; U Eisel; H Niemann; C Widmann; G Corradin
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Ovalbumin injected with complete Freund's adjuvant stimulates cytolytic responses.

Authors:  Y Ke; Y Li; J A Kapp
Journal:  Eur J Immunol       Date:  1995-02       Impact factor: 5.532

8.  Epitope repertoire of human CD4+ lines propagated with tetanus toxoid or with synthetic tetanus toxin sequences.

Authors:  R Raju; B Diethelm-Okita; D Okita; B M Conti-Fine
Journal:  J Autoimmun       Date:  1996-02       Impact factor: 7.094

9.  Complement C3b fragment covalently linked to tetanus toxin increases lysosomal sodium dodecyl sulfate-stable HLA-DR dimer production.

Authors:  V A Serra; F Cretin; E Pépin; F M Gabert; P N Marche
Journal:  Eur J Immunol       Date:  1997-10       Impact factor: 5.532

10.  Tetanus toxin is a zinc protein and its inhibition of neurotransmitter release and protease activity depend on zinc.

Authors:  G Schiavo; B Poulain; O Rossetto; F Benfenati; L Tauc; C Montecucco
Journal:  EMBO J       Date:  1992-10       Impact factor: 11.598

View more
  2 in total

1.  Isolation and characterization of new human carrier peptides from two important vaccine immunogens.

Authors:  Paeton L Wantuch; Lina Sun; Rachel K LoPilato; Jarrod J Mousa; Robert S Haltiwanger; Fikri Y Avci
Journal:  Vaccine       Date:  2020-01-28       Impact factor: 3.641

2.  Synthetic Cannabinoid-Induced Immunosuppression Augments Cerebellar Dysfunction in Tetanus-Toxin Treated Mice.

Authors:  Jaesuk Yun; Sun Mi Gu; Tac-Hyung Lee; Yun Jeong Song; Seonhwa Seong; Young-Hoon Kim; Hye Jin Cha; Kyoung Moon Han; Jisoon Shin; Hokyung Oh; Kikyung Jung; Chiyoung Ahn; Hye-Kyung Park; Hyung Soo Kim
Journal:  Biomol Ther (Seoul)       Date:  2017-05-01       Impact factor: 4.634

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.